BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 15663993)

  • 1. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate.
    Adams JY; Leav I; Lau KM; Ho SM; Pflueger SM
    Prostate; 2002 Jun; 52(1):69-81. PubMed ID: 11992621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.
    Risbridger G; Wang H; Young P; Kurita T; Wang YZ; Lubahn D; Gustafsson JA; Cunha G
    Dev Biol; 2001 Jan; 229(2):432-42. PubMed ID: 11150243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase and prostate cancer.
    Ellem SJ; Risbridger GP
    Minerva Endocrinol; 2006 Mar; 31(1):1-12. PubMed ID: 16498360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual, opposing roles of estrogen in the prostate.
    Ellem SJ; Risbridger GP
    Ann N Y Acad Sci; 2009 Feb; 1155():174-86. PubMed ID: 19250203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
    Bonkhoff H; Berges R
    Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-regulated development and differentiation of the prostate.
    McPherson SJ; Ellem SJ; Risbridger GP
    Differentiation; 2008 Jul; 76(6):660-70. PubMed ID: 18557760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.
    Singh PB; Matanhelia SS; Martin FL
    Eur J Cancer; 2008 May; 44(7):928-36. PubMed ID: 18381236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens and mechanisms of prostate cancer progression.
    Carruba G
    Ann N Y Acad Sci; 2006 Nov; 1089():201-17. PubMed ID: 17261768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anterior prostate epithelial AR inactivation modifies estrogen receptor expression and increases estrogen sensitivity.
    Simanainen U; McNamara K; Gao YR; McPherson S; Desai R; Jimenez M; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E727-35. PubMed ID: 21750267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S; Wang X; Ng CF; Chen S; Chan FL
    Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormones and carcinogenesis of the prostate: the role of estrogens.
    Ricke WA; Wang Y; Cunha GR
    Differentiation; 2007 Nov; 75(9):871-82. PubMed ID: 17924963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate.
    Attia DM; Ederveen AG
    Prostate; 2012 Jun; 72(9):1013-22. PubMed ID: 22025007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.